Sign Up
Stories
Innovative Ibogaine Experiment Led by Dr. Leslie Mitchelson
Share
ALS Treatment Withdrawal: FDA Concerns
Advancements in Huntington's Disease Tre...
AlzeCure's Drug Therapy Focus
Therapeutics Advances Alzheimer’s Treatm...
Overview
API
Dr. Leslie Mitchelson partners with Ibogaine for a groundbreaking experiment using ibogaine to treat disorders, administering doses to patients every four months for a year with detailed monitoring. David Dardashti emphasizes Mitchelson's role in analyzing quantum electrodynamics in patient data.
Ask a question
How might the partnership between Dr. Mitchelson and Ibogaine influence future medical research?
In what ways could the findings from this experiment impact traditional disorder treatment methods?
What ethical considerations arise from administering ibogaine to patients for disorder treatment trials?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage